Cycloserine Capsules and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
Determining the interaction of Cycloserine Capsules and Kisqali Femara Co-Pack 400 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cycloserine
Brand name: Seromycin
Synonyms: Cycloserine, CycloSERINE
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cycloserine Capsules-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Cycloserine Capsules-Kitabis Pak
- Cycloserine Capsules-Kitabis Pak inhalation
- Cycloserine Capsules-Klofensaid II
- Cycloserine Capsules-Klonopin
- Cycloserine Capsules-Klonopin Wafer
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Cycloset
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Cyclosporine
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-CycloSPORINE (Systemic)
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Cyclosporine Capsules
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Cyclosporine Capsules, Modified
- Kisqali Femara Co-Pack 400 mg-2.5 mg Dose-Cyclosporine Injection